Even though the coronavirus crisis forced adult-use marijuana dispensaries in Massachusetts to stop sales for a while, they’re now back in action, and after the close Thursday, Trulieve Cannabis Corp. (CSE:TRUL) (OTC:TCNNF), a multi-state operator, announced that it received unanimous approval for three adult-use licenses in addition to their three medical licenses.
Here’s what you need to know…
- Trulieve Cannabis Corp. received unanimous approval for its Adult-Use/Recreational Provisional License from the Massachusetts Cannabis Control Commission to operate as a Tier 9 indoor cultivation and to carry out product manufacturing in Holyoke, Massachusetts.
- The CCC also awarded Trulieve its Adult-Use/Recreational Provisional License to operate a retail cannabis establishment in Northampton, Massachusetts.
- Trulieve intends to co-locate the adult-use cannabis licenses at their facilities in Holyoke and Northampton, where they currently have their vertically integrated provisional medical licenses for cultivation, product manufacturing, and retail operations in place.
- “We are looking forward to being operational in Massachusetts and bringing the Trulieve brand to the state,” commented Trulieve CEO Kim Rivers.
- Shares of CSE:TRUL closed up slightly at $17.76 CAD per share on Thursday, June 4th, 2020.
Be sure toΒ subscribe to cannabis stock updates here so you never miss an important update. To read the full Trulieve Cannabis Corp. press release, click here.
Get Real-Time Updates from MJobserver.com